my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Biotie is a drug development company focusing on dependence disorders, inflammatory diseases and thrombosis. The most advanced drugs in development are nalmefene for alcoholism (phase III) and impulse control disorders (phase II), monoclonal VAP-1 antibody and small molecule VAP-1 SSAO enzyme inhibi more
David Cook, 45, has been appointed Chief Financial Officer (CFO) of Biotie Therapies Corp., effective February 25, 2013. He will become a member of the Group's management team and will report to Timo Veromaa, President and Chief Executive Officer. David will be based at the Company's headquarters in more
Biotie reported top-line data from a Phase 2b study evaluating its adenosine A2a antagonist tozadenant (SYN115) in Parkinson's disease (PD) patients experiencing levodopa related end of dose wearing off. The study met its primary endpoint of a statistically highly significant decrease in 'off' time more
Biotie's chief financial officer (CFO) Panu Miettinen is leaving the company from 1st November 2012 to pursue other interests. Kristian Rantala (36), M.Sc. (Econ), Vice President, Finance based in Finland has been nominated as the interim CFO. Kristian has been with Biotie for altogether two years a more
Introduction GlobalData, the industry analysis specialist, has released its new report, “Posttraumatic Stress Disorder Therapeutics (PTSD) - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Post-Traumatic Stress Disorder more
Introduction GlobalData, the industry analysis specialist, has released its new report, “Post-Traumatic Stress Disorder (PTSD) Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Post-Traumatic Stress Disorder more
Biotie Therapies Corp. (Biotie) is a biotechnology company, engaged in the discovery and development of therapeutics for the treatment of central nervous system and inflammatory diseases. The company's develops pipeline products which includes, Nalmefene is an opioid receptor antagonist for alcohol more
Skip to Content Skip over Generic Navigation Global Web Site Roche Worldwide Deutsch Site Map Contact Skip over Primary Navigation Home About Roche Products Corporate Responsibility Research & Development Media Investors Careers Skip over Subnavigations At a Glance Management Corporate Governance Bu more
Free Newsletter! BioValley.com BioValley Region Home About BioValley BioValley Guide News Events Links Job Market Contact Us Press releases and articles Focus of the month International News Newsletter » Top Viewed » Most Commented Related Topics » Research » Biotechnology » Development more
T +44 1279 645645 E argenta@glpg.com Innovation. Expertise. Delivered Home About Argenta Services News & Publications Careers Contact Us In this section... Company Profile Working with Argenta Clients & Testimonials Company History Management Team Facilities Clients & Testimonials Clients Argenta wo more
Biotie Therapies Biotie Therapies () is a Finnish biotechnology and pharmaceutics company. The company's research and development is focused on dependence disorders, inflammatory diseases and thrombosis . The company's headquarter is located ... more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
